In the last issue of Capitol Connections, IACP’s bi-monthly eNewsletter, we featured Dr. Wolfberg’s editorial regarding the compounded 17-P hydroxyprogesterone and KV Pharmaceutical debacle. IACP responded to Dr. Wolfberg’s article by sending him a letter of support.

Click here to view “Progesterone: The Oldest ‘New’ Drug to Nearly Reach the Market”

Click here to view IACP’s response